SHR-9839

· Shanghai Hengrui Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SHR-9839, covering 2024-06-25 to 2025-08-11. Get the full timeline:

Most recent: Clinical Trial Update: The Clinical Study of SHR-9839 for Injection in Patients With Advanced Solid Tumors [Phase 1]